831
Views
36
CrossRef citations to date
0
Altmetric
Research Article

Aminoglycoside antibiotics cochleotoxicity in paediatric cystic fibrosis (CF) patients: A study using extended high-frequency audiometry and distortion product otoacoustic emissions

, , , &
Pages 112-122 | Received 08 Nov 2009, Accepted 09 Sep 2010, Published online: 25 Jan 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Malcolm A. Gleser & Erika M. Zettner. (2018) Negative hearing effects of a single course of IV aminoglycoside therapy in cystic fibrosis patients. International Journal of Audiology 57:12, pages 923-930.
Read now
L Petersen & C Rogers. (2015) Aminoglycoside-induced hearing deficits – a review of cochlear ototoxicity. South African Family Practice 57:2, pages 77-82.
Read now

Articles from other publishers (33)

Adam J. Kimple, Brent A. Senior, Edward T. Naureckas, David A. Gudis, Ted Meyer, Sarah E. Hempstead, Helaine E. Resnick, Dana Albon, Wayne Barfield, Margo McKenna Benoit, Daniel M. Beswick, Eliza Callard, Shelagh Cofer, Veronica Downer, E. Claire Elson, Angela Garinis, Ashleigh Halderman, Lisa Hamburger, Meagan Helmick, Michael McCown, Cameron J. McKinzie, Hanna Phan, Kenneth Rodriguez, Ronald C. Rubenstein, Ashley Severin, Gopi Shah, Ambika Shenoy, Brittney Sprouse, Frank Virgin, Bradford A. Woodworth & Stella E. Lee. (2022) Cystic Fibrosis Foundation otolaryngology care multidisciplinary consensus recommendations. International Forum of Allergy & Rhinology 12:9, pages 1089-1103.
Crossref
Leonard P. Rybak, Debashree Mukherjea & Vickram Ramkumar. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 732 754 .
Min Dong, Anna V Rodriguez, Chelsea A Blankenship, Gary McPhail, Alexander A Vinks & Lisa L Hunter. (2021) Pharmacokinetic modelling to predict risk of ototoxicity with intravenous tobramycin treatment in cystic fibrosis. Journal of Antimicrobial Chemotherapy 76:11, pages 2923-2931.
Crossref
Chelsea M. Blankenship, Lisa L. Hunter, M. Patrick Feeney, Madison Cox, Lindsey Bittinger, Angela C. Garinis, Li Lin, Gary McPhail & John P. Clancy. (2021) Functional Impacts of Aminoglycoside Treatment on Speech Perception and Extended High-Frequency Hearing Loss in a Pediatric Cystic Fibrosis Cohort. American Journal of Audiology 30:3S, pages 834-853.
Crossref
Sophie Magréault, Charlotte Roy, Manon Launay, Isabelle Sermet-Gaudelus & Vincent Jullien. (2021) Pharmacokinetic and Pharmacodynamic Optimization of Antibiotic Therapy in Cystic Fibrosis Patients: Current Evidences, Gaps in Knowledge and Future Directions. Clinical Pharmacokinetics 60:4, pages 409-445.
Crossref
E. Emily Harruff, Jonathan Kil, Maria Gabriela Tupayachi Ortiz, Daniel Dorgan, Raksha Jain, Elizabeth A. Poth, Robert C. Fifer, Yun Jin M. Kim, Angela G. Shoup & Patrick A. Flume. (2021) Ototoxicity in cystic fibrosis patients receiving intravenous tobramycin for acute pulmonary exacerbation. Journal of Cystic Fibrosis 20:2, pages 288-294.
Crossref
Angela Garinis, Malcolm Gleser, Alexis Johns, Erik Larsen & Jay Vachhani. (2021) Prospective cohort study of ototoxicity in persons with cystic fibrosis following a single course of intravenous tobramycin. Journal of Cystic Fibrosis 20:2, pages 278-283.
Crossref
Dagny Hemmingsen, Camilla Mikalsen, Alexander Rydland Hansen, Jon Widding Fjalstad, Niels Christian Stenklev & Claus Klingenberg. (2020) Hearing in Schoolchildren After Neonatal Exposure to a High-Dose Gentamicin Regimen. Pediatrics 145:2.
Crossref
Jacqueline M. Ogier, Paul J. Lockhart & Rachel A. Burt. (2020) Intravenously delivered aminoglycoside antibiotics, tobramycin and amikacin, are not ototoxic in mice. Hearing Research 386, pages 107870.
Crossref
Chaitanya Mamillapalli, Asmita Dhukhwa, Sandeep Sheth, Debashree Mukherjea, Leonard P. Rybak & Vickram Ramkumar. 2020. New Therapies to Prevent or Cure Auditory Disorders. New Therapies to Prevent or Cure Auditory Disorders 51 87 .
Meiyan Jiang, Hongzhe Li, Anastasiya Johnson, Takatoshi KarasawaYuan ZhangWilliam B. Meier, Farshid Taghizadeh, Allan KachelmeierPeter S. Steyger. (2019) Inflammation up-regulates cochlear expression of TRPV1 to potentiate drug-induced hearing loss. Science Advances 5:7.
Crossref
O. D. Ostroumova, E. V. Chikh, E. V. Rebrova, A. Yu. Ryazanova & A. P. Pereverzev. (2019) Drug-induced hearing loss as a manifestation of drug-induced ototoxicity. Vestnik otorinolaringologii 84:4, pages 72.
Crossref
Erika M. Zettner & Malcolm A. Gleser. (2018) Progressive Hearing Loss among Patients with Cystic Fibrosis and Parenteral Aminoglycoside Treatment. Otolaryngology–Head and Neck Surgery 159:5, pages 887-894.
Crossref
Angela C. GarinisDouglas H. KeefeLisa L. HunterDenis F. FitzpatrickDaniel B. PuttermanGarnett P. McMillanJeffrey A. GoldM. Patrick Feeney. (2018) Chirp-Evoked Otoacoustic Emissions and Middle Ear Absorbance for Monitoring Ototoxicity in Cystic Fibrosis Patients. Ear & Hearing 39:1, pages 69-84.
Crossref
Mary E. O’Sullivan, Adela Perez, Randy Lin, Autefeh Sajjadi, Anthony J. Ricci & Alan G. Cheng. (2017) Towards the Prevention of Aminoglycoside-Related Hearing Loss. Frontiers in Cellular Neuroscience 11.
Crossref
C. Behr, H. Kamp, E. Fabian, G. Krennrich, W. Mellert, E. Peter, V. Strauss, T. Walk, I. M. C. M. Rietjens & B. van Ravenzwaay. (2017) Gut microbiome-related metabolic changes in plasma of antibiotic-treated rats. Archives of Toxicology 91:10, pages 3439-3454.
Crossref
Jaynee A. Handelsman, Samya Z. Nasr, Crystal Pitts & William M. King. (2017) Prevalence of hearing and vestibular loss in cystic fibrosis patients exposed to aminoglycosides. Pediatric Pulmonology 52:9, pages 1157-1162.
Crossref
Debora T.M. Caumo, Lúcia B. Geyer, Adriane R. Teixeira & Sérgio S.M. Barreto. (2017) Hearing thresholds at high frequency in patients with cystic fibrosis: a systematic review. Brazilian Journal of Otorhinolaryngology 83:4, pages 464-474.
Crossref
Angela C. Garinis, Campbell P. Cross, Priya Srikanth, Kelly Carroll, M. Patrick Feeney, Douglas H. Keefe, Lisa L. Hunter, Daniel B. Putterman, David M. Cohen, Jeffrey A. Gold & Peter S. Steyger. (2017) The cumulative effects of intravenous antibiotic treatments on hearing in patients with cystic fibrosis. Journal of Cystic Fibrosis 16:3, pages 401-409.
Crossref
Zewen Gao, Ye Chen & Min-Xin Guan. (2017) Mitochondrial DNA mutations associated with aminoglycoside induced ototoxicity. Journal of Otology 12:1, pages 1-8.
Crossref
Daniel J. Fox, Morris D. Cooper, Cristian A. Speil, Melissa H. Roberts, Susan C. Yanik, Robert P. Meech, Tim L. Hargrove, Steven J. Verhulst, Leonard P. Rybak & Kathleen C.M. Campbell. (2016) d -Methionine reduces tobramycin-induced ototoxicity without antimicrobial interference in animal models. Journal of Cystic Fibrosis 15:4, pages 518-530.
Crossref
Joseph FosterIIII & Mustafa Tekin. (2016) Aminoglycoside induced ototoxicity associated with mitochondrial DNA mutations. Egyptian Journal of Medical Human Genetics 17:3, pages 287-293.
Crossref
Renata Almeida Araújo Silvestre, Ângela Ribas, Rogério Hammerschmidt & Adriana Bender Moreira de Lacerda. (2016) High‐frequency profile in adolescents and its relationship with the use of personal stereo devices. Jornal de Pediatria (Versão em Português) 92:2, pages 206-211.
Crossref
Renata Almeida Araújo Silvestre, Ângela Ribas, Rogério Hammerschmidt & Adriana Bender Moreira de Lacerda. (2016) High-frequency profile in adolescents and its relationship with the use of personal stereo devices. Jornal de Pediatria 92:2, pages 206-211.
Crossref
Zainab Farzal, Yann-Fuu Kou, Rachel St. John, Gopi B. Shah & Ron B. Mitchell. (2016) The role of routine hearing screening in children with cystic fibrosis on aminoglycosides: A systematic review. The Laryngoscope 126:1, pages 228-235.
Crossref
Lucia Bencke Geyer, Sergio Saldanha Menna Barreto, Liese Loureiro Weigert & Adriane Ribeiro Teixeira. (2015) High frequency hearing thresholds and product distortion otoacoustic emissions in cystic fibrosis patients. Brazilian Journal of Otorhinolaryngology 81:6, pages 589-597.
Crossref
Ghada Al-Malky, Sally J. Dawson, Tony Sirimanna, Emmanouil Bagkeris & Ranjan Suri. (2015) High-frequency audiometry reveals high prevalence of aminoglycoside ototoxicity in children with cystic fibrosis. Journal of Cystic Fibrosis 14:2, pages 248-254.
Crossref
Ghada Al-Malky, Ranjan Suri, Tony Sirimanna & Sally J. Dawson. (2014) Normal hearing in a child with the m.1555A>G mutation despite repeated exposure to aminoglycosides. Has the penetrance of this pharmacogenetic interaction been overestimated?. International Journal of Pediatric Otorhinolaryngology 78:6, pages 969-973.
Crossref
Amir Houshang Mehrparvar, Seyyed Jalil Mirmohammadi, Mohammad Hossein Davari, Mehrdad Mostaghaci, Abolfazl Mollasadeghi, Maryam Bahaloo & Seyyed Hesam Hashemi. (2014) Conventional Audiometry, Extended High-Frequency Audiometry, and DPOAE for Early Diagnosis of NIHL. Iranian Red Crescent Medical Journal 16:1.
Crossref
Daniel Peckham & Paul Whitaker. (2013) Drug induced complications; can we do more?. Journal of Cystic Fibrosis 12:6, pages 547-558.
Crossref
Veronica Melchionda, Harry Wyatt, Santino Capocci, Raul Garcia Medina, Angelita Solamalai, Sotira Katiri, Susan Hopkins, Ian Cropley & Marc Lipman. (2013) Amikacin treatment for multidrug resistant tuberculosis: how much monitoring is required?. European Respiratory Journal 42:4, pages 1148-1150.
Crossref
Jing Xie, Andra E. Talaska & Jochen Schacht. (2011) New developments in aminoglycoside therapy and ototoxicity. Hearing Research 281:1-2, pages 28-37.
Crossref
M. E. Huth, A. J. Ricci & A. G. Cheng. (2011) Mechanisms of Aminoglycoside Ototoxicity and Targets of Hair Cell Protection. International Journal of Otolaryngology 2011, pages 1-19.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.